Medtech Matters
Podcast autorstwa Medical Product Outsourcing
154 Odcinki
-
3 Most Common Premarket (Postmarket?) Review Issues FDA Sees
Opublikowany: 25.06.2025 -
Why Are One-Third of MAUDE Reports a Problem?
Opublikowany: 10.06.2025 -
FDA Guidance on Off-Label Communication, Part 2
Opublikowany: 30.05.2025 -
FDA Guidance on Off-Label Communication, Part 1
Opublikowany: 30.05.2025 -
Development Considerations for Over-the-Counter Medtech, Part 1
Opublikowany: 23.01.2025 -
Development Considerations for OTC Medtech, Part 2
Opublikowany: 23.01.2025 -
Device Descriptions in Regulatory Submissions
Opublikowany: 7.01.2025 -
Regulatory Ramifications Due to the Presidential Election
Opublikowany: 26.11.2024 -
Regulatory Considerations with an Assisted Suicide Machine
Opublikowany: 20.11.2024 -
Predetermined Change Control Plans, Part 2
Opublikowany: 24.09.2024 -
Predetermined Change Control Plans, Part 1
Opublikowany: 24.09.2024 -
What is a CAPA and How Do You Best Use It?
Opublikowany: 3.09.2024 -
You Got a 483 from the FDA. Now what?
Opublikowany: 22.08.2024 -
Revisiting Real-World Evidence
Opublikowany: 18.06.2024 -
The Most Dangerous Devices to Hit the Market
Opublikowany: 11.06.2024 -
Headline-Generating Medical Device Safety Concerns
Opublikowany: 2.05.2024 -
Analyzing ECRI’s 2024 Top 10 Health Technology Hazards
Opublikowany: 19.03.2024 -
Examining Institutional Review Boards
Opublikowany: 6.03.2024 -
Reimbursing Breakthrough Designation Products
Opublikowany: 2.01.2024 -
Strengthening the 510k Program
Opublikowany: 19.12.2023
A podcast focused on the medical device technology industry, from design and development to outsourcing services and relationships to finished medtech products.
